Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
Barry S Komm, Sebastian MirkinPfizer Inc, Collegeville, PA, USAAbstract: Many women experience bothersome vasomotor and vaginal symptoms during the menopausal transition. Decreasing levels of estrogens during menopause are also associated with reduced bone density and an increased risk of osteoporos...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-03-01
|
| Series: | International Journal of Women's Health |
| Online Access: | http://www.dovepress.com/incorporating-bazedoxifeneconjugated-estrogens-into-the-current-paradi-a9595 |